by APAR Secretariat | Apr 17, 2021 | Bulletin
by APAR Secretariat | Apr 17, 2021 | Bulletin
The war against ongoing COVID-19 pandemic may have silently brought a dark face of humanity where plenty of vaccines have been stockpiled by rich and affordable nations leaving a number of doses, even nothing for the poor nations and regions. Recent reports have found...
by APAR Secretariat | Apr 17, 2021 | Bulletin
Two COVID-19 vaccines developed by AstraZeneca and J&J have developed rare blood clot events during inoculation program after these were approved for use. AstraZeneca vaccine that has been widely approved across many nations has been halted by more than a dozen...
by APAR Secretariat | Apr 17, 2021 | Bulletin
Since its first international delivery to Ghana on February 25, the COVAX has delivered more than 38 million doses of vaccines from manufacturers AstraZeneca, Pfizer-BioNTech and Serum Institute of India (SII) vaccines to over 100 middle or lower income economies...
by APAR Secretariat | Apr 17, 2021 | Bulletin
If you are Anti-vaxxer, have vaccine anxiety or find it difficult for getting appointment to take the shot yet want protection from COVID-19, this may be the news for you. Thanks to the breakthrough innovation of SaNotize, a Canada based biotech company. Using on its...
